HOITT JASON (Chief Commercial Officer) sold 38.0% of their position (7.58K shares) of DOVA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $115.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/16/2019ACC: 0001209191-19-042168
Officer· Chief Commercial Officer
Since Dec 2018
-7.58K
Net shares
Net seller
$115.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.58K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.68K
Price / share
$15.10
Trade value
$100.87K
% of position
33.5%
7/15/2019
19.94K→13.26K
Common Stock
Direct
Shares
−900.00
Price / share
$16.44
Trade value
$14.80K
% of position
6.8%
7/15/2019
13.26K→12.36K
Total
Net shares
−7.58K
Net value
-$115.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2019 | S · Sale | −6.68K | $15.10 | $100.87K | 33.5% | 19.94K | 13.26K |
| Common Stock Direct | 7/15/2019 | S · Sale | −900.00 | $16.44 | $14.80K | 6.8% | 13.26K | 12.36K |
| Total | −7.58K | -$115.66K | ||||||
Derivative Transactions0
No derivative transactions reported